STEVEN EBERS: Open Payments
NPI 1578056800 · POTOSI, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$499 in 30 payments from 15 companies in 2025. Trend: 2023 $525 · 2024 $851 · 2025 $499
Food & beverage: $499
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 12 | $150 |
| Lilly USA, LLC | 2 | $41 |
| Aimmune Therapeutics, Inc. | 2 | $38 |
| Teva Pharmaceuticals USA, Inc. | 2 | $36 |
| Grifols USA, LLC | 2 | $32 |
| Otsuka America Pharmaceutical, Inc. | 1 | $32 |
| HARMONY BIOSCIENCES LLC | 1 | $29 |
| Dexcom, Inc. | 1 | $26 |
| Indivior Inc. | 1 | $23 |
| Neurocrine BioSciences, Inc. | 1 | $17 |
Products named: VRAYLAR, MOUNJARO, UZEDY, Prolastin-C Liquid, REXULTI, WAKIX, MAVYRET, Dexcom G6 Transmitter.
Industry payments across MO — which companies pay providers there.
